Cinctive Capital Management’s Pfizer PFE Stock Holding History

Cinctive Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-90,000	Closed	-$5.32M	–	619
2021 Q4	$5.32M	Buy	+90,000	New	+$4.46M	0.23%	143

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cinctive Capital Management's PFE Position: Q2 2026 in Review

Cinctive Capital Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 31,828 shares — an estimated $894K sold.

Cinctive Capital Management first reported a position in PFE in Q4 2021 and held it in 11 quarters. The position peaked at $15.2M in Q2 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cinctive Capital Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Cinctive Capital Management sold 31,828 Pfizer shares in Q2 2026, an estimated $894K.
Cinctive Capital Management first reported a position in Pfizer in Q4 2021 and held it in 11 quarters.
Cinctive Capital Management's Pfizer position peaked at $15.2M in Q2 2024.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.